Peripheral Artery Disease – Japan Drug Forecast and Market Analysis to 2024
In the 2014 base year, the global PAD market was worth approximately $543.4m, including both branded and generic drugs. By 2024, Global Data expects that the global PAD market will experience significant expansion, with a Compound Annual Growth Rate (CAGR) of approximately 4.15%, equating to around $816.3m. The dramatic increase in the value of the overall global PAD therapeutics market will be partly attributable to the launch of several PAD drugs currently in late-stage pipeline development, which Global Data believes have extraordinary potential. These include the novel antithrombotic pharmacological agents, Merck & Co.s Zontivity (vorapaxar), AstraZenecas Brilinta (ticagrelor), and Bayer and Janssens (a subsidiary of Johnson & Johnson) Xarelto (rivaroxaban), which have the capacity to reform the antiplatelet and anticoagulatory PAD treatment landscape.
Browse Full Report with Toc : http://www.acutemarketreports.com/report/peripheral-artery-disease-japan-drug-forecast-and-market-analysis-to-2024
In the 2014 base year, GlobalData determined that the PAD therapeutics market in Japan was worth $59.5m. The remainder of the 2014 PAD market in Japan came from prostaglandins, which are used to ameliorate the symptoms of PAD, and cilostazol, which is used as an antiplatelet agent in this market. In total, these drugs generated approximately $31.4m in 2014.
*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.
For Same Category Reports Visit Here: http://www.acutemarketreports.com/category/healthcare-market
– Overview of PAD including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
– Detailed information on the key drugs in Japan including product PADcription, safety and efficacy profiles as well as a SWOT analysis.
– Sales forecast for the top drugs in Japan from 2014-2024.
– Analysis of the impact of key events as well the drivers and restraints affecting Japan PAD market.
Reasons to buy
– Understand and capitalize by identifying products that are most likely to ensure a robust return
– Stay ahead of the competition by understanding the changing competitive landscape for PAD.
– Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
– Make more informed business decisions from insightful and in-depth analysis of drug performance
– Obtain sales forecast for drugs from 2014-2024 in Japan.
For Technology News: http://www.mobilecomputingtoday.co.uk/
About – Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements .We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : email@example.com
Website : http://www.acutemarketreports.com